Company news
Phio Pharmaceuticals Corp. news in 2021
Phio Pharmaceuticals Corp.'s news releases, calls and decks from 2021, newest first.
Phio Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
November 9, 2021
Phio Pharmaceuticals Announces Upcoming Presentation at the SITC 36th Annual Meeting
October 17, 2021
Phio Pharmaceuticals Announces Two Upcoming Data Presentations at Scientific Conferences in October 2021
September 29, 2021
Phio Pharmaceuticals Presents Data at ESMO 2021 Demonstrating Persistent Anti-Tumor Immunity with INTASYL Dual-Targeting PD-1 and BRD4
September 15, 2021
Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021
August 30, 2021
Phio Pharmaceuticals Presents New In Vivo Data at the 2021 ASCO Annual Meeting Showing Dual-Targeting INTASYL Offers Increased Efficacy and Safety Potential Over Other Therapeutic Approaches
June 3, 2021
Phio Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
May 12, 2021
Phio Pharmaceuticals Presents Positive In Vivo Data at ASGCT Showing PH-762 Significantly Enhanced Antitumor Efficacy of HER2-Targeted CAR-T Cells
May 10, 2021
Phio Pharmaceuticals Announces Upcoming Data Presentations at the ASGCT and ASCO Annual Meetings
April 28, 2021
Phio Pharmaceuticals Presents Positive In Vivo Data Showing Strong Tumor Control for the Intratumoral Delivery of INTASYL™ RNAi Targeting PD-1
April 9, 2021
Phio Pharmaceuticals Reports 2020 Year End Financial Results and Provides Business Update
March 24, 2021
Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies
February 28, 2021
Phio Pharmaceuticals Announces Closing of $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market
February 16, 2021
Phio Pharmaceuticals Announces $7.7 Million Registered Direct Offering of Common Stock Priced At-the-Market
February 11, 2021
Phio Pharmaceuticals Announces Closing of $14.0 Million Private Placement Priced At-the-Market
January 24, 2021
Phio Pharmaceuticals Announces $14.0 Million Private Placement Priced At-the-Market
January 20, 2021